HST Global, Inc. (HSTC)

↓ Download CSV

CIK 0000797564 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

In fiscal 2023, HST Global, Inc. reported revenue of $0. The company ran a net loss. It held $1.5K in total assets against $593.6K in total liabilities.

Metric (FY)2023202220212020201920182017201620152014
Revenue$0$0$0$0$0$0$0
Operating Income-$140.9K-$141.0K-$145.7K-$208.0K-$151.6K-$142.6K-$153.0K-$137.3K-$160.0K-$149.0K
Net Income-$146.2K-$145.1K-$148.4K-$209.0K$426.6K-$178.3K-$165.1K-$173.0K-$195.8K-$184.7K
EPS (Diluted)$-0.03$-0.03$-0.03
Total Assets$1.5K$190$225$660$2.0K$0$291$465$195$164
Total Liabilities$593.6K$446.0K$301.0K$153.1K$5.4K$3.37M$3.19M$3.03M$2.85M$2.66M
Shareholders' Equity-$592.1K-$445.9K-$300.8K-$152.4K-$3.4K-$3.37M-$3.19M-$3.03M-$2.85M-$2.66M
Cash & Equivalents$1.5K$190$225$660$2.0K$0$291$465$195$164
Operating Cash Flow-$20.9K-$21.0K-$29.8K-$27.0K-$91.9K-$21.1K-$29.9K-$21.9K-$17.6K-$24.6K
Shares Outstanding5.25M5.25M5.25M5.25M4.25M2.45M36.72M